LB PHARMACEUTICALS INC SEC EDGAR Filings (CIK 0001691082)

SEC EDGAR filings, ownership reports, and insider transactions for LB PHARMACEUTICALS INC.

Symbol
LBRX on Nasdaq
Industry
Pharmaceutical Preparations (Office Of Life Sciences)
Business address
575 Madison Avenue, New York, NY, 10022
State of incorporation
DE
Fiscal year end
31 December
⭐ Add to watchlist ⭐
Get insider transactions for this issuer
LB PHARMACEUTICALS INC has filed 77 SEC EDGAR filings since 15 Dec 2016

Latest Filings

Recent SEC filings for LB PHARMACEUTICALS INC including SCHEDULE 13G, 4, 3 and more.

Form type Document Filing Description Filing date Reporting date File number(s)
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 31 Dec 2025 005-95235
4 Open 4 document View SEC filing for 4 11 Dec 2025 10 Dec 2025
3 Open 3 document View SEC filing for 3 18 Nov 2025 10 Nov 2025
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 13 Nov 2025 10 Nov 2025 001-42831
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 12 Nov 2025 12 Nov 2025 001-42831
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 06 Nov 2025 30 Sep 2025 001-42831
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 06 Nov 2025 06 Nov 2025 001-42831
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 17 Oct 2025 005-95235
4 Open 4 document View SEC filing for 4 29 Sep 2025 10 Sep 2025
3 Open 3 document View SEC filing for 3 29 Sep 2025 10 Sep 2025
SCHEDULE 13D Open SCHEDULE 13D document View SEC filing for SCHEDULE 13D 25 Sep 2025 005-95235
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 19 Sep 2025 005-95235
SCHEDULE 13D Open SCHEDULE 13D document View SEC filing for SCHEDULE 13D 19 Sep 2025 005-95235
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 18 Sep 2025 005-95235
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 18 Sep 2025 005-95235
4 Open 4 document View SEC filing for 4 16 Sep 2025 12 Sep 2025
3 Open 3 document View SEC filing for 3 16 Sep 2025 12 Sep 2025
4 Open 4 document View SEC filing for 4 16 Sep 2025 12 Sep 2025
4 Open 4 document View SEC filing for 4 16 Sep 2025 12 Sep 2025
4 Open 4 document View SEC filing for 4 4 16 Sep 2025 12 Sep 2025
4 Open 4 document View SEC filing for 4 12 Sep 2025 10 Sep 2025
4 Open 4 document View SEC filing for 4 12 Sep 2025 10 Sep 2025
4 Open 4 document View SEC filing for 4 12 Sep 2025 10 Sep 2025
4 Open 4 document View SEC filing for 4 12 Sep 2025 10 Sep 2025
4 Open 4 document View SEC filing for 4 12 Sep 2025 10 Sep 2025
4 Open 4 document View SEC filing for 4 12 Sep 2025 10 Sep 2025
4 Open 4 document View SEC filing for 4 12 Sep 2025 10 Sep 2025
4 Open 4 document View SEC filing for 4 12 Sep 2025 10 Sep 2025
4 Open 4 document View SEC filing for 4 12 Sep 2025 10 Sep 2025
4 Open 4 document View SEC filing for 4 12 Sep 2025 10 Sep 2025
4 Open 4 document View SEC filing for 4 12 Sep 2025 10 Sep 2025
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 12 Sep 2025 12 Sep 2025 001-42831
424B4 Open 424B4 document View SEC filing for 424B4 424B4 12 Sep 2025 333-289812
3 Open 3 document View SEC filing for 3 11 Sep 2025 10 Sep 2025
3 Open 3 document View SEC filing for 3 11 Sep 2025 10 Sep 2025
3 Open 3 document View SEC filing for 3 11 Sep 2025 10 Sep 2025
S-8 Open S-8 document | Open XBRL data View SEC filing for S-8 S-8 11 Sep 2025 333-290180
EFFECT Open EFFECT document View SEC filing for EFFECT 10 Sep 2025 333-289812
3 Open 3 document View SEC filing for 3 10 Sep 2025 10 Sep 2025
S-1MEF Open S-1MEF document | Open XBRL data View SEC filing for S-1MEF S-1MEF 10 Sep 2025 333-290182
3 Open 3 document View SEC filing for 3 10 Sep 2025 10 Sep 2025
3 Open 3 document View SEC filing for 3 10 Sep 2025 10 Sep 2025
3 Open 3 document View SEC filing for 3 10 Sep 2025 10 Sep 2025
3 Open 3 document View SEC filing for 3 10 Sep 2025 10 Sep 2025
3 Open 3 document View SEC filing for 3 10 Sep 2025 10 Sep 2025
3 Open 3 document View SEC filing for 3 10 Sep 2025 10 Sep 2025
3 Open 3 document View SEC filing for 3 10 Sep 2025 10 Sep 2025
3 Open 3 document View SEC filing for 3 10 Sep 2025 10 Sep 2025
3 Open 3 document View SEC filing for 3 10 Sep 2025 10 Sep 2025
3 Open 3 document View SEC filing for 3 10 Sep 2025 10 Sep 2025
CERT Open CERT document View SEC filing for CERT 10 Sep 2025 001-42831
8-A12B Open 8-A12B document View SEC filing for 8-A12B 8-A12B 09 Sep 2025 001-42831
CORRESP Open CORRESP document View SEC filing for CORRESP 09 Sep 2025
CORRESP Open CORRESP document View SEC filing for CORRESP 09 Sep 2025
S-1/A Open S-1/A document | Open XBRL data View SEC filing for S-1/A S-1/A 08 Sep 2025 333-289812
CORRESP Open CORRESP document View SEC filing for CORRESP 03 Sep 2025
S-1 Open S-1 document | Open XBRL data View SEC filing for S-1 S-1 22 Aug 2025 333-289812
CORRESP Open CORRESP document View SEC filing for CORRESP 22 Aug 2025
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 12 Aug 2025 377-07237
DRS/A Open DRS/A document View SEC filing for DRS/A 23 Jul 2025 377-07237
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 23 Jul 2025
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 02 Jul 2024 377-07237
DRS/A Open DRS/A document View SEC filing for DRS/A 24 Jun 2024 377-07237
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 24 Jun 2024
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 17 Jun 2024 377-07237
DRS Open DRS document View SEC filing for DRS 20 May 2024 377-07237
D/A Open D/A document View SEC filing for D/A 10 Jan 2024 021-492682
D Open D document View SEC filing for D 21 Sep 2023 021-492682
D/A Open D/A document View SEC filing for D/A 23 Nov 2022 021-463476
D Open D document View SEC filing for D 01 Nov 2022 021-463476
D Open D document View SEC filing for D 06 Jul 2022 021-451258
D Open D document View SEC filing for D 01 Sep 2020 021-374620
D Open D document View SEC filing for D 12 Dec 2018 021-327722
D Open D document View SEC filing for D 27 Aug 2018 021-320086
D Open D document View SEC filing for D 29 May 2018 021-313419
D Open D document View SEC filing for D 06 Apr 2017 021-284184
D Open D document View SEC filing for D 15 Dec 2016 021-276363

About this filer

LB PHARMACEUTICALS INC files with the SEC under CIK 0001691082. This page aggregates EDGAR filings and related ownership activity.

Industry: Pharmaceutical Preparations.

See insider transactions for this issuer.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages